INFLUENZA VACCINES – AUSTRALIA

CSL to step up flu vaccine production

roymorgansocial Leave a comment

Original article by Jared Lynch
The Australian – Page: 15 : 20-Apr-20

CSL subsidiary Seqirus will produce an additional two million doses of the influenza vaccine, amid strong demand during the coronavirus pandemic. Danielle Dowell of Seqirus says the company is set to supply a record number of flu shots during the 2020 flu season, and stresses that consumers should call their pharmacy or medical clinic ahead of time to ensure that the vaccine is available. The federal government will provide 13.5 million free flu shots via its National Immunisation Program. The flu vaccine does not provide protection against the coronavirus.

CORPORATES
CSL LIMITED – ASX CSL, SEQIRUS PTY LTD, SIGMA HEALTHCARE LIMITED – ASX SIG, AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED – ASX API

CSL launches $1b share buyback

roymorgansocial Leave a comment

Original article by Tim Binsted
The Australian Financial Review – Page: 15 : 16-Oct-15

Australian-listed CSL forecasts that its Seqirus influenza division will post revenue of $US450m and a break-even profit in 2015-16, before making a profit in 2017-18. Seqirus has been established by merging the BioCSL division with the recently acquired flu vaccines arm of Novartis. Meanwhile, CSL will repurchase some $A1bn of its shares over the next year. It will be the group’s ninth buyback in the last decade.

CORPORATES
CSL LIMITED – ASX CSL, BIOCSL, SEQIRUS, NOVARTIS AG, UBS HOLDINGS PTY LTD